Lipidor AB (Nasdaq First North: LIPI) announced today that the Company has signed a new cooperation agreement with Aurena Laboratories AB. Over a five-year period, Lipidor will invest up to SEK 15

STOCKHOLM den 4 mars 2021 – Lipidor AB (Nasdaq First North: LIPI) meddelar idag att bolagets vd Ola Holmlund tillsammans med Stina Linge, vd för

Bolaget tillförs genom emissionen cirka 1 150 nya aktieägare. Lipidor AB (publ) (www.lipidor.se) är ett svenskt stockholmsbaserat forsknings- och utvecklingsbolag med en pipeline av läkemedelsutvecklingsprojekt i preklinisk och klinisk fas. Bolaget utvecklar läkemedel för behandling av hudsjukdomar som psoriasis, bakteriella hudinfektioner och atopisk dermatit genom omformulering av välbeprövade läkemedelssubstanser. 2020-10-14 2020-09-30 Nasdaq Nordic Nasdaq Stockholm welcomes Lipidor to the Nasdaq First North Growth Market. Stockholm, September 27, 2019 – Nasdaq (Nasdaq: NDAQ) announces that the trading in Lipidor AB’s shares (short name: LIPI) will commence today on the Nasdaq First North Growth Market in Stockholm. Lipidor belongs to the health care sector and is the 42 nd company to be admitted to trading on Nasdaq… LIPIDOR AB (PUBL) : News, information and stories for LIPIDOR AB (PUBL) | NASDAQ OMX STOCKHOLM: LIPI | NASDAQ OMX STOCKHOLM Lipidor AB is a Sweden-based drug delivery company focusing on topical medication.

Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis. Lipidor AB (Nasdaq First North:LIPI) today announced that the company has signed an exclusive licensing agreement with Cannassure Therapeutics Ltd. (TASE:CSURE), an Israeli company specializing in the development and manufacture of innovative medicinal cannabis products.The license agreement was drafted and negotiated by Synch´s Sara Sparring. LIPI, Lipidor, (SE0012558617) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic.

Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. 2019-09-27 · Stockholm, September 27, 2019– Nasdaq announces that the trading in Lipidor AB’ s shares will commence today on the Nasdaq First North Growth Market in Stockholm.

ÅAC Microtec · ÅAC Microtec AB BTA · AAK · Aallon Group Oyj · Aarhus Karlshamn Lipidor · Lipigon Pharmaceuticals · Lipum · Liseberg · Litauen · Litium Näringsliv · Näringslivet · Nasdaq · Nasdaq OMX · NasdaqOMX

COMPANIES LISTED ON NASDAQ FIRST NORTH PREMIER Growth Market. Companies below are listed on Nasdaq First North Premier Growth Market. For viewing other markets or segments, please use the links in the right column.

Karolinska Development (Nasdaq Stockholm: KDEV) announces that its portfolio company Lipidor AB has been approved for listing on Nasdaq First North

Lipidor's growth journey continues, and the completion of the management team is a key step in the company's development. Lipidor AB was founded in 2009 based on a unique, patented formulation technology, AKVANO. AKVANO has been shown in clinical studies to improve estab-lished skin remedies by making them more effective and easier to apply. Lipidor is in a position with clear potential value-creating activities in the coming years and the Company is in Stockholm, September 27, 2019 - Nasdaq (Nasdaq: NDAQ) announces that the trading in Lipidor AB's shares (short name: LIPI) will commence today on the Nasdaq First North Growth Market in Stockholm. Lipidor AB is a Sweden-based drug delivery company focusing on topical medication. The Company is focused to develop, patent and commercialize formulation concepts and technologies based on lipids.

On 30 th September, a positive outcome from the company's feasibility study was published in collaboration with Cannassure Therapeutics Ltd., for the development of medical cannabis based on the company's AKVANO® … I fredags den 13 september 2019 avslutades teckningstiden i Lipidor AB:s (”Bolaget”) noteringsemission av units inför notering på Nasdaq First North Growth Market.
Positiv forsterkning barn

Køb Lipidor AB (LIPI) aktien. Hos Nordnet kan du handle fra 0 kr. i kurtage.

Köp aktier i Lipidor - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Nasdaq Stockholm AB har idag godkänt Lipidor AB:s (”Lipidor” eller ”Bolaget”) ansökan om upptagande till handel av Bolagets aktier och teckningsoptioner av serie TO1 på Nasdaq First North Growth Market (”Nasdaq First North”).
Nakdcom one world ab göteborg

när slutar man få barnbidrag
sintercast cgi
räntebärande tillgångar lund
skattebrottsutredare utbildning
servicecenter örebro

STOCKHOLM den 4 mars 2021 – Lipidor AB (Nasdaq First North: LIPI) meddelar idag Erik Penser Bank, Lipidor. 2 dagar sedan Pressmeddelande Från och

STOCKHOLM den 14 oktober 2020: Lipidor AB (publ) (”Lipidor” eller ”Bolaget”) (Nasdaq First North: LIPI) offentliggör härmed att lösenpriset för teckningsoptioner av serie TO1 2019 (”LIPI TO1” eller ”Teckningsoptioner”) har fastställts till 9,95 SEK. Styrelsen i Lipidor AB (”Lipidor” eller ”Bolaget”) har beslutat att genomföra en nyemission om högst 2 100 000 units (”Erbjudandet”) samt notera Bolagets aktier på Nasdaq First North Growth Market (”Nasdaq First North”). Teckningskursen per unit är 12 kr och varje unit består av två (2) aktier med teckningskurs om 6 kr per aktie samt en (1) Stockholm, 1 October 2020: Lipidor AB (Nasdaq First North: LIPI) today announces that the company is strengthening its management team through the recruitment of Anders Hagman as Chief Development Officer. Hagman will assume the role as of 1 October 2020.